Avenue Therapeutics, Inc. Gains 22.67%
Mon, Jul 18, 2022 at 07:09 PM
Avenue Therapeutics, Inc. (ATXI:NASDAQ) rocketted at $0.32, representing a gain of 22.7%. On Mon, Jul 18, 2022, ATXI:NASDAQ touched a New 2-Week High of $0.32. From Tue, Jul 05, 2022, the stock recorded 22.22% Up Days and 40.00% Green Days
The stock spiked on Wed, Jun 29, 2022 at $0.4 with a volume of 3M+.
About Avenue Therapeutics, Inc. (ATXI:NASDAQ)
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of an intravenous, or IV, formulation of tramadol HCl, or IV Tramadol, for the management of moderate to moderately severe postoperative pain.
Top 10 Gainers:
- AMTD Digital Inc. American Depositary Shares (every five of which represent two Class A) (HKD:NYSE), 71.5%
- SQL Technologies Corp. (SKYX:NASDAQ), 43.15%
- Qudian Inc. (QD:NYSE), 40.34%
- Intelligent Living Application Group Inc. (ILAG:NASDAQ), 37.78%
- Exela Technologies, Inc. (XELA:NASDAQ), 34.33%
- Troika Media Group Inc. (TRKA:NASDAQ), 31.52%
- Tantech Holdings Ltd (TANH:NASDAQ), 23.12%
- Avenue Therapeutics, Inc. (ATXI:NASDAQ), 22.67%
- EzFill Holdings Inc. (EZFL:NASDAQ), 22.52%
- Boxed Inc. (BOXD:NYSE), 21.67%